Reddick
Andrew D. Reddick, Exton, PA US
Caryn Reddick, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090293019 | USER INTERFACE HAVING SLIDER CONTROLS FOR WEIGHTED PARAMETERS IN SEARCHING OR DECISION MAKING PROCESSES - User interface having slider controls for weighted parameters in searching or decision making processes. Slider controls may correspond to certain search parameters, which may be given more or less weight in searching depending on the user's adjustments to the position of the slider controls. A sliding display element may also include a display icon that changes with respect to the position of a slider control, in real-time. Search results may also be updated in real-time based on user input. | 11-26-2009 |
Catherine Reddick, Orange, NJ US
Patent application number | Description | Published |
---|---|---|
20140221389 | USE OF 4-AMINO-5-FLUORO-3-[6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL- ]-1H-QUINOLIN-2-ONE IN THE TREATMENT OF CANCER IN MODERATE HEPATIC IMPAIRED PATIENTS - The present invention relates to a method of treating a cancer in patient in need thereof by administering 4-amino-5 fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one, or a tautomer thereof, or a salt of any one of them, wherein the patient is a moderate hepatic impaired patient. | 08-07-2014 |
Catherne Reddick, Orange, NJ US
Patent application number | Description | Published |
---|---|---|
20140378422 | Combination of a RTK inhibitor with an anti-estrogen and use thereof for the treatment of cancer - A pharmaceutical combination comprising (a) a RTK inhibitor selected from the group consisting of compounds of Formula I or a tautomer thereof, compounds of Formula II or a tautomer thereof, compounds of Formula III or a tautomer thereof, a pharmaceutically acceptable salt of the compound, a pharmaceutically acceptable salt of the tautomer, or a mixture thereof; and (b) one or more anti-estrogen compounds, or a pharmaceutically acceptable salt thereof; such as tamoxifen, toremifene, fulvestrant, raloxifene or raloxifene hydrochloride; the uses of such combination in the treatment or prevention of proliferative diseases: and methods of treating a subject suffering from a proliferative disease; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination. | 12-25-2014 |
Charles E. Reddick, Palatka, FL US
Patent application number | Description | Published |
---|---|---|
20080224928 | GPS for communications facility records - Methods and systems are disclosed for enhancing line records with Global Positioning System coordinates. Global Positioning System information is acquired and associated with an address. A line record is assembled for the address using the Global Positioning System information. | 09-18-2008 |
20090289848 | GPS for Communications Facility Records - Methods and systems are disclosed for enhancing line records with Global Positioning System coordinates. Global Positioning System information is acquired and a line record is assembled for an address using the Global Positioning System information. | 11-26-2009 |
Edwin Matthew Reddick, Clemmons, NC US
Patent application number | Description | Published |
---|---|---|
20140255452 | METHOD AND APPARATUS FOR DIFFERENTIATING ORAL POUCH PRODUCTS - A nicotine-containing pharmaceutical product configured for insertion into the mouth of a user of that product is provided. The product can have an outer water-permeable pouch, a nicotine-containing pharmaceutical composition situated within the outer water-permeable pouch, and product identifying information relating to the nicotine-containing pharmaceutical composition. The information can be presented such that a user of the product can discern the identifying information by visually inspecting the product and thereby differentiate or identify certain nicotine-containing pharmaceutical products. The product identifying can be, for example, printed, imprinted or dyed on the outer water-permeable pouch, positioned within the outer water-permeable pouch, or attached to the outer water-permeable pouch. The product identifying information can identify product brand, a company name, a corporate logo or brand, marketing messages, product strength, active ingredient, product manufacture date, product expiration date, product flavor, product pharmaceutical release profile, weight, product code, other product differentiating markings, and combinations thereof. | 09-11-2014 |
E. Matthew Reddick, Clemmons, NC US
Patent application number | Description | Published |
---|---|---|
20120103353 | SMOKELESS TOBACCO PRODUCTS - A smokeless tobacco product is provided. A tobacco product configured for insertion into the mouth of a user of that product comprises a water-permeable pouch containing a tobacco formulation that includes a granular tobacco composition, wherein the pouch comprises a fleece material configured to provide enhanced flavor. | 05-03-2012 |
Jared B. Reddick, Dunnellon, FL US
Patent application number | Description | Published |
---|---|---|
20130199355 | Drum Pedal Cover - A drum pedal cover for attachment to a drum pedal surface is hereby disclosed. Single or multiple layers of padded foam material are employed, which are attached to the drum pedal surface. The padded material is used to reduce shock and provide comfort to the user during drumming. The drum pedal cover is attached to the drum pedal surface by employing the use of several strap assemblies, which are woven through apertures in the drum pedal cover. The strap assembly winds underneath the drum pedal's surface and is attached from the underside of the drum pedal. The strap assembly enables the user to rapidly employ and deploy the invention. | 08-08-2013 |
Matt Reddick, Clemmons, NC US
Patent application number | Description | Published |
---|---|---|
20130078307 | NICOTINE-CONTAINING PHARMACEUTICAL COMPOSITION - A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy. | 03-28-2013 |
20150071972 | NICOTINE-CONTAINING PHARMACEUTICAL COMPOSITION - A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy. | 03-12-2015 |
Randolph S. Reddick, Calhoun, GA US
Patent application number | Description | Published |
---|---|---|
20100015448 | Special Turf Filler - An aggregate turf filler for use with the turf of athletic fields and landscaped areas which comprise crushed silica sand particles (SiO | 01-21-2010 |
20110183086 | FILLER FOR ARTIFICIAL TURF SYSTEM - Artificial turf for use with an artificial turf system, which may also include a base layer and a support layer. The artificial turf comprising a backing supporting pile tufts of between ¼″ to 4″ in length, in position on its upper surface. The backing may comprise a porous synthetic foam or backing sheet. A filler of particles shaped to have no sharp edges and of substantially equal size are interspersed over the backing and about the tufts up to at least half thick length. The artificial turf substantially retains its resiliency, porosity and equal density throughout. | 07-28-2011 |
20120027962 | Special Turf Filler - An aggregate turf filler for use with the turf of athletic fields and landscaped areas which comprise crushed silica sand particles (SiO | 02-02-2012 |
20130034671 | Chlorophyll cooling agent for synthetic turf components - An artificial turf is disclosed having a base and a plurality of synthetic fibers attached to and extending upward from the base, the fibers comprising a chlorin-based organic colorant and the colorant reflects infrared radiation in the range of 700 to 1,100 nm. | 02-07-2013 |
20150044395 | FILLER FOR ARTIFICIAL TURF SYSTEM - Artificial turf for use with an artificial turf system, which may also include a base layer and a support layer. The artificial turf comprising a backing supporting pile tufts of between ¼′ to 4″ in length, in position on its upper surface. The backing may comprise a porous synthetic foam or backing sheet. A filler of particles shaped to have no sharp edges and of substantially equal size are interspersed over the backing and about the tufts up to at least half thick length. The artificial turf substantially retains its resiliency, porosity and equal density throughout. | 02-12-2015 |
Wilburn E. Reddick, Bartlett, TN US
Patent application number | Description | Published |
---|---|---|
20140270453 | T2 SPECTRAL ANALYSIS FOR MYELIN WATER IMAGING - Apparatus, methods, and other embodiments associated with the spectral analysis of T | 09-18-2014 |
William Patrick Reddick, Marietta, GA US
Patent application number | Description | Published |
---|---|---|
20100129418 | METHOD OF INDUCING NEGATIVE CHEMOTAXIS USING AN ELLAGITANNIN OR GALLOTANNIN - The current invention is directed to methods of inducing the negative chemotaxis of a migratory cell comprising contacting the cell with a compound selected from the group consisting of an ellagitannin and a gallotannin. In one embodiment, the compound is ellagic acid or a pharmaceutically acceptable salt thereof. | 05-27-2010 |